Indel Therapeutics
Vancouver · Founded 2008
About Indel Therapeutics
Indel Therapeutics Inc. is a Vancouver based biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company has a growing pipeline of novel antibiotic drug discovery programs focused on curing difficult to treat and hospital acquired infections. These programs are based on Indel's paradigm changing antimicrobial drug discovery platform, a patented technology that that has opened a rich, new area of antimicrobial drug targets for the treatment of infectious diseases and has the potential to provide an advantage against drug resistance.
Company Facts
- Founded: 2008
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $1.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2011)
- Website: http://www.indeltherapeutics.com/
- Phone: (604)551-8464
Industries & Categories
Biotechnology, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/indel-therapeutics-1907420 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.